Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The potential impact of intervention strategies on COVID-19 transmission in Malawi: A mathematical modelling study

Tara D. Mangal, Charlie Whittaker, Dominic Nkhoma, Wingston Ng’ambi, Oliver J Watson, Patrick Walker, Azra Ghani, Paul Revill, Tim Colbourn, Andrew Phillips, Timothy B. Hallett, Joseph Mfutso-Bengo
doi: https://doi.org/10.1101/2020.10.06.20207878
Tara D. Mangal
1Medical Research Council Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: t.mangal@imperial.ac.uk
Charlie Whittaker
1Medical Research Council Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominic Nkhoma
2Health Economics & Policy Unit, College of Medicine, University of Malawi, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wingston Ng’ambi
2Health Economics & Policy Unit, College of Medicine, University of Malawi, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver J Watson
1Medical Research Council Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Walker
1Medical Research Council Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azra Ghani
1Medical Research Council Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Revill
3Centre for Health Economics, University of York, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Colbourn
4Institute for Global Health, University College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Phillips
4Institute for Global Health, University College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy B. Hallett
1Medical Research Council Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Mfutso-Bengo
2Health Economics & Policy Unit, College of Medicine, University of Malawi, Malawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background COVID-19 mitigation strategies have been challenging to implement in resource-limited settings such as Malawi due to the potential for widespread disruption to social and economic well-being. Here we estimate the clinical severity of COVID-19 in Malawi, quantifying the potential impact of intervention strategies and increases in health system capacity.

Methods The infection fatality ratios (IFR) in Malawi were estimated by adjusting reported IFR for China accounting for demography, the current prevalence of comorbidities and health system capacity. These estimates were input into an age-structured deterministic model, which simulated the epidemic trajectory with non-pharmaceutical interventions. The impact of a novel therapeutic agent and increases in hospital capacity and oxygen availability were explored, given different assumptions on mortality rates.

Findings The estimated age-specific IFR in Malawi are higher than those reported for China, however the younger average age of the population results in a slightly lower population-weighted IFR (0.48%, 95% uncertainty interval [UI] 0.30% – 0.72% compared with 0.60%, 95% CI 0.4% – 1.3% in China). The current interventions implemented, (i.e. social distancing, workplace closures and public transport restrictions) could potentially avert 3,100 deaths (95% UI 1,500 – 4,500) over the course of the epidemic. Enhanced shielding of people aged ≥ 60 years could avert a further 30,500 deaths (95% UI 17,500 – 45,600) and halve ICU admissions at the peak of the outbreak. Coverage of face coverings of 60% under the assumption of 50% efficacy could be sufficient to control the epidemic. A novel therapeutic agent, which reduces mortality by 0.65 and 0.8 for severe and critical cases respectively, in combination with increasing hospital capacity could reduce projected mortality to 2.55 deaths per 1,000 population (95% UI 1.58 – 3.84).

Conclusion The risks due to COVID-19 vary across settings and are influenced by age, underlying health and health system capacity.

What is already known?

  • As COVID-19 spreads throughout Sub-Saharan Africa, countries are under increasing pressure to protect the most vulnerable by suppressing spread through, for example, stringent social distancing measures or shielding of those at highest risk away from the general population.

  • There are a number of studies estimating infection fatality ratio due to COVID-19 but none use data from African settings. The estimated IFR varies across settings ranging between 0.28-0.99%, with higher values estimated for Europe (0.77%, 95% CI 0.55 – 0.99%) compared with Asia (0.46%, 95% CI 0.38 – 0.55).

  • The IFR for African settings are still unknown, although several studies have highlighted the potential for increased mortality due to comorbidities such as HIV, TB and malaria.

  • There are a small number of studies looking at the impact of non-pharmaceutical interventions in Africa, particularly South Africa, but none to date have combined this with country-specific estimates of IFR adjusted for comorbidity prevalence and with consideration to the prevailing health system constraints and the impact of these constraints on mortality rates.

What are the new findings?

  • After accounting for the health system constraints and differing prevalences of underlying comorbidities, the estimated infection fatality ratio (IFR) for Malawi (0.48%, 95% uncertainty interval 0.30% – 0.72%) is within the ranges reported for the Americas, Asia and Europe (overall IFR 0.70, 95% CI 0.57 – 0.82, range 0.28 – 0.89).

  • Introducing enhanced shielding of people aged ≥ 60 years could avert up to 30,500 deaths (95% UI 17,500 – 45,600) and significantly reduce demand on ICU admissions.

  • Maintaining coverage of face coverings at 60%, under the assumption of 50% efficacy, could be sufficient to control the epidemic.

  • Combining the introduction of a novel therapeutic agent with increases in hospital capacity could reduce projected mortality to 2.55 deaths per 1,000 population (95% UI 1.58 – 3.84).

What do the new findings imply?

  • Adjusting estimates of COVID-19 severity to account for underlying health is crucial for predicting health system demands.

  • A multi-pronged approach to controlling transmission, including face coverings, increasing hospital capacity and using new therapeutic agents could significantly reduce deaths to COVID-19, but is not as effective as a theoretical long-lasting lockdown.

Competing Interest Statement

Prof Hallett reports grants from MRC, during the conduct of the study; grants from BMGF, MRC, UNAIDS, WHO, NIH, personal fees from The Global Fund, WHO, BMGF, outside the submitted work;.

Funding Statement

Dr Mangal, Prof Hallett, Prof Phillips, Dr Colbourn, Prof Mfutso-Bengo, Mr Revill, Dr Nkhoma and Mr Ng'ambi are supported by UK Research and Innovation as part of the Global Challenges Research Fund, grant number MR/P028004/1 TM, CW, PW, OJW, AG and TBH acknowledge joint Centre funding from the UK Medical Research Council and Department for International Development. Grant reference: MR/R015600/1

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB/ethical approval was required as this is a theoretical modelling study using publicly available data

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used in the analyses are publicly available and sources have been listed for each.

https://github.com/mrc-ide/squire

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted October 07, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The potential impact of intervention strategies on COVID-19 transmission in Malawi: A mathematical modelling study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The potential impact of intervention strategies on COVID-19 transmission in Malawi: A mathematical modelling study
Tara D. Mangal, Charlie Whittaker, Dominic Nkhoma, Wingston Ng’ambi, Oliver J Watson, Patrick Walker, Azra Ghani, Paul Revill, Tim Colbourn, Andrew Phillips, Timothy B. Hallett, Joseph Mfutso-Bengo
medRxiv 2020.10.06.20207878; doi: https://doi.org/10.1101/2020.10.06.20207878
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The potential impact of intervention strategies on COVID-19 transmission in Malawi: A mathematical modelling study
Tara D. Mangal, Charlie Whittaker, Dominic Nkhoma, Wingston Ng’ambi, Oliver J Watson, Patrick Walker, Azra Ghani, Paul Revill, Tim Colbourn, Andrew Phillips, Timothy B. Hallett, Joseph Mfutso-Bengo
medRxiv 2020.10.06.20207878; doi: https://doi.org/10.1101/2020.10.06.20207878

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4800)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (69)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5278)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (764)
  • Public and Global Health (1795)
  • Radiology and Imaging (320)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (254)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)